Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-12-22

FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for ELELYSO (taliglucerase alfa) submitted by Pfizer Laboratories Div Pfizer Inc, resulting in changes to the product la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELELYSO (TALIGLUCERASE ALFA)

Snippet

SUPPL AP for ELELYSO (TALIGLUCERASE ALFA)